Ten63 Therapeutics

BiotechnologySeries ADurham, USten63tx.com

Latest round

Series A

Last raised

May 2023

Total raised

$16M

Investors

7

About Ten63 Therapeutics

Based in Durham Fwy, North Carolina, US, and founded in 2018, Ten63 Therapeutics provides a platform, Copper, that leverages its proprietary physical models to allow its users to discover new therapeutics to targets previously believed undruggable. Ten63 Therapeutics is the developer of a platform that allows anyone to challenge diseases to a chess match, one that is played through evolutionary time. The result is novel therapeutics that are resilient to the emergence of drug resistance and able to modulate previously undruggable targets.

Who invested in Ten63 Therapeutics

7 investors across 3 rounds

See all investors in Ten63 Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 2, 2023

    Amount

    $16M

    Investors

    Locked

  2. Seed

    Jan 7, 2021

    Amount

    Undisclosed

    Investors

    Locked

  3. Seed

    Oct 27, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about Ten63 Therapeutics

Who invested in Ten63 Therapeutics?

Ten63 Therapeutics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ten63 Therapeutics raised?

Ten63 Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Ten63 Therapeutics last raise money?

Ten63 Therapeutics's most recent round on record is a Series A, in May 2023.

What does Ten63 Therapeutics do?

Based in Durham Fwy, North Carolina, US, and founded in 2018, Ten63 Therapeutics provides a platform, Copper, that leverages its proprietary physical models to allow its users to discover new therapeutics to targets previously believed undruggable.

Where is Ten63 Therapeutics headquartered?

Ten63 Therapeutics is headquartered in Durham, US.

Which VCs invest in companies like Ten63 Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ten63 Therapeutics's stage. Their profiles are linked below.

Raising like Ten63 Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.